MA27677A1 - Azoles, procedes pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation - Google Patents
Azoles, procedes pour leur preparation, compositions pharmaceutiques les contenant et leur utilisationInfo
- Publication number
- MA27677A1 MA27677A1 MA25480A MA25480A MA27677A1 MA 27677 A1 MA27677 A1 MA 27677A1 MA 25480 A MA25480 A MA 25480A MA 25480 A MA25480 A MA 25480A MA 27677 A1 MA27677 A1 MA 27677A1
- Authority
- MA
- Morocco
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- formula
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Azoles, procédé pour leur préparation, compositions pharmaceutiques les contenant et leur utilisation L'invention décrit des dérivés de type azole de formule I dans laquelle R14 et R15 représentent chacun indépendamment un atome d'hydrogène ou de fluor, T est un groupe de formule ou formules dans lesquelles R9 est un groupe pyrrolidinyle ou A-NH-B- ; A est un atome d'hydrogène ou un groupe alkyle en C1-C5 à chaîne droite ou ramifiée; B est un groupe alkylène en C1-C4 à chaîne droite ou ramifiée, -CH2-CONH-CH2 ou -CH2CH2CH2-CH(NH2); et X- est un anion pharmaceutiquement acceptable ; et les sels pharmaceutiquement acceptables de tels composés et les hydrates et produits de solvatation des composés de formule I et de leurs sels, des procédés pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation dans la fabrication de médicaments destinés au traitement d'infections fongiques et de mycoses.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98104036 | 1998-03-06 | ||
EP98123310 | 1998-12-08 | ||
EP99101360 | 1999-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27677A1 true MA27677A1 (fr) | 2006-01-02 |
Family
ID=27239027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25480A MA27677A1 (fr) | 1998-03-06 | 1999-03-02 | Azoles, procedes pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation |
Country Status (6)
Country | Link |
---|---|
US (1) | US6300353B1 (fr) |
AR (1) | AR018303A1 (fr) |
AU (1) | AU2931399A (fr) |
MA (1) | MA27677A1 (fr) |
PE (1) | PE20000328A1 (fr) |
WO (1) | WO1999045008A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6812238B1 (en) | 1999-11-02 | 2004-11-02 | Basilea Pharmaceutica Ag | N-substituted carbamoyloxyalkyl-azolium derivatives |
BRPI0015254C1 (pt) * | 1999-11-02 | 2021-05-25 | Basilea Pharmaceutica Ag | compostos derivados de carbamoiloxialquil-azólio, seu uso, bem como composição farmacêutica compreendendo os mesmos. |
HUP0303249A3 (en) | 2001-02-22 | 2007-03-28 | Sankyo Co | Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them |
CA2497195C (fr) | 2001-12-14 | 2014-07-08 | The University Of Wyoming | Methodes et compositions de liberation controlee de medicaments |
CN1819998B (zh) | 2003-07-18 | 2010-09-08 | 株式会社钟化 | 光学活性卤代醇衍生物及用其的光学活性环氧醇衍生物的制法 |
JP4404611B2 (ja) * | 2003-11-27 | 2010-01-27 | 住友化学株式会社 | エポキシトリアゾール化合物の製造方法及びその中間体 |
DE102004059725A1 (de) | 2004-12-11 | 2006-06-22 | Bayer Cropscience Ag | 2-Alkyl-cycloalk(en)yl-carboxamide |
AU2006319657B2 (en) * | 2005-12-01 | 2010-08-12 | Basilea Pharmaceutica Ag | Process for the manufacture of epoxybutanol intermediates |
AU2008290536B2 (en) | 2007-08-21 | 2012-02-09 | Basilea Pharmaceutica Ag | Antifungal composition |
US8207352B2 (en) * | 2009-10-08 | 2012-06-26 | Drug Process Licensing Associates LLC | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole |
WO2014023623A1 (fr) | 2012-08-07 | 2014-02-13 | Basilea Pharmaceutica Ag | Procédé pour la fabrication d'isavuconazole ou ravuconazole |
WO2015150947A1 (fr) * | 2014-03-29 | 2015-10-08 | Wockhardt Limited | Procédé de préparation de l'isavuconazole et de ses intermédiaires |
WO2016055918A1 (fr) | 2014-10-08 | 2016-04-14 | Wockhardt Limited | Nouveaux polymorphes stables d'isavuconazole ou de son sel |
CN106565699B (zh) * | 2015-10-10 | 2019-07-26 | 江苏正大丰海制药有限公司 | 一种艾沙康唑硫酸盐晶体及其制备方法 |
CN105367528A (zh) * | 2015-11-10 | 2016-03-02 | 南通诺泰生物医药技术有限公司 | 一种***类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法 |
CN108452848B (zh) * | 2016-02-24 | 2020-12-11 | 上海兰立生物科技有限公司 | 一种催化剂 |
EP3584245A4 (fr) * | 2017-02-17 | 2020-08-26 | Wuhan LL Science And Technology Development Co., Ltd. | Dérivé antibactérien de triazole, composition pharmaceutique et utilisation associées |
CN108558846B (zh) * | 2018-05-17 | 2020-07-07 | 天津莱茵泰克生物科技有限公司 | 艾莎康唑中间体的合成方法及其应用 |
CN110498774A (zh) * | 2018-05-18 | 2019-11-26 | 上海医药工业研究院 | 一种艾沙康唑中间体的制备方法 |
WO2021245590A1 (fr) * | 2020-06-04 | 2021-12-09 | Metrochem Api Private Limited | Procédé amélioré pour la préparation de dérivés de triazole |
JP7454905B2 (ja) * | 2021-09-28 | 2024-03-25 | 旭化成ファーマ株式会社 | 有効成分であるイサブコナゾール又はそのプロドラッグを含有する真菌症治療及び/又は予防剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861879A (en) | 1983-02-28 | 1989-08-29 | Janssen Pharmaceutica N.V. | [[4-[4-Phenyl-1-piperazinyl)phenoxymethyl]-1-3-dioxolan-2-yl]-methyl]-1H-imidazoles and 1H-1,2,4-triazoles |
GB9107055D0 (en) * | 1991-04-04 | 1991-05-22 | Pfizer Ltd | Triazole antifungal agents |
NZ270418A (en) * | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
NZ328607A (en) | 1996-09-09 | 1999-08-30 | Hoffmann La Roche | Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions |
AU726495B2 (en) * | 1996-09-09 | 2000-11-09 | F. Hoffmann-La Roche Ag | N-benzylazolium derivatives |
-
1999
- 1999-03-01 WO PCT/EP1999/001327 patent/WO1999045008A1/fr active Application Filing
- 1999-03-01 AU AU29313/99A patent/AU2931399A/en not_active Abandoned
- 1999-03-02 MA MA25480A patent/MA27677A1/fr unknown
- 1999-03-02 PE PE1999000171A patent/PE20000328A1/es not_active Application Discontinuation
- 1999-03-04 AR ARP990100912A patent/AR018303A1/es active IP Right Grant
- 1999-03-05 US US09/263,027 patent/US6300353B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PE20000328A1 (es) | 2000-05-08 |
WO1999045008A1 (fr) | 1999-09-10 |
AR018303A1 (es) | 2001-11-14 |
AU2931399A (en) | 1999-09-20 |
US6300353B1 (en) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27677A1 (fr) | Azoles, procedes pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation | |
BE901224A (fr) | Nouveaux derives d'indole utiles comme medicaments et intermediaires et procedes pour leur preparation. | |
CA2656716C (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
MA26952A1 (fr) | Derives d'imidazole a noyau aryle ou heteroaryle condense, utiles comme agents anti-inflammatoires et analgesiques. | |
KR100214453B1 (ko) | 경피적 관상동맥 형성술 후의 재협착 억제제 | |
TNSN96172A1 (fr) | Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
NZ335013A (en) | Compositions comprising cytosine derivatives for the treatment of cancer | |
TNSN05073A1 (fr) | Quinazolinones spirocondensees nouvelles et leur utilisation comme inhibiteurs de phosphodiesterase | |
MA27990A1 (fr) | Derives de piperazine pour le traitement d'infections par le vih | |
MA28747B1 (fr) | Dérivés de pyridine | |
MA26717A1 (fr) | Macrolides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
KR930004296A (ko) | 신규(2-알킬-3-피리딜)메틸피페라진 유도체 | |
KR970704710A (ko) | 트리아졸 화합물 및 도파민 D₃리간드로서의 그의 용도(Triazole Compounds and Their Use as Dopamine-D₃-Ligands) | |
MA30014B1 (fr) | Derives spirocycliques | |
TNSN98151A1 (fr) | Derives de 2 - (4 - aryl - ou heteroaryl - piperazine - 1 - ylmethyl) -1 h - indole. | |
MA27795A1 (fr) | Derives d'amine cycliques, procedes de preparation de ceux-ci et compositions pharmaceutiques les contenant | |
CA2246485A1 (fr) | Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
NO304373B1 (no) | Imidazol-derivater, farmas°ytiske preparater inneholdende dem og anvendelse av dem | |
MA30308B1 (fr) | Dérivés de benzoisoindole utilisés dans le traitement de la douleur | |
KR860008973A (ko) | 2-피롤리돈 유도체 | |
MA24721A1 (fr) | Compositions nouvelles renfermant des derives de benzopyranne et pyrydopyranne et procede pour leur preparation | |
DK283984D0 (da) | Benzodiazepinderivater og fremgangsmaade til fremstilling deraf | |
ES2004410A6 (es) | Porcedimiento para la preparacion e nuevos derivados benzohidrilpiperazinas | |
CA2366829A1 (fr) | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA27947A1 (fr) | Pyrimidines 2-substituees |